| Age
| Female
| Male
|
| Premature (26-28 weeks)
| 110-1376 ng/dL
| 110-1376 ng/dL
|
| Premature (29-36 weeks)
| 70-455 ng/dL
| 70-455 ng/dL
|
| Full Term (1-5 months)
| 10-200 ng/dL
| 10-200 ng/dL
|
| 6-11 months
| 10-276 ng/dL
| 10-276 ng/dL
|
| 1-3 years
| 7-247 ng/dL
| 7-202 ng/dL
|
| 4-6 years
| 8-291 ng/dL
| 8-235 ng/dL
|
| 7-9 years
| Less than or equal to 94 ng/dL
| Less than or equal to 120 ng/dL
|
| 10-12 years
| Less than or equal to 123 ng/dL
| Less than or equal to 92 ng/dL
|
| 13-15 years
| Less than or equal to 107 ng/dL
| Less than or equal to 95 ng/dL
|
| 16-17 years
| Less than or equal to 47 ng/dL
| Less than or equal to 106 ng/dL
|
| 18 years and older
| Less than 33 ng/dL
| Less than 50 ng/dL
|
| Tanner Stage I
| Less than or equal to 94 ng/dL
| Less than or equal to 105 ng/dL
|
| Tanner Stage II
| Less than or equal to 136 ng/dL
| Less than or equal to 108 ng/dL
|
| Tanner Stage III
| Less than or equal to 99 ng/dL
| Less than or equal to 111 ng/dL
|
| Tanner Stage IV & V
| Less than or equal to 50 ng/dL
| Less than or equal to 83 ng/dL
|
| After metyrapone stimulation
| Greater than 8000 ng/dL
| Greater than 8000 ng/dL
|
|